These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6336716)

  • 41. The appearance of eosinophil-directed chemotactic inhibitory factor in the serum of complete Freund's adjuvant-treated guinea pigs.
    Hirashima M; Tashiro K; Hayashi H
    Cell Immunol; 1984 Nov; 89(1):113-21. PubMed ID: 6488330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice.
    Teixeira MM; Talvani A; Tafuri WL; Lukacs NW; Hellewell PG
    J Leukoc Biol; 2001 Mar; 69(3):353-60. PubMed ID: 11261781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM; König W; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1978; 56(5):398-408. PubMed ID: 344231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of eosinophilic leukocytes in inflammatory dermatoses].
    Czarnetzki BM
    Hautarzt; 1980 Jun; 31(6):291-6. PubMed ID: 6997234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review on the natural mediators of inflammatory leucotaxis.
    Hayashi H
    Acta Pathol Jpn; 1982; 32 Suppl 2():271-84. PubMed ID: 6765002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A newly described activity of guinea pig IgG1 antibodies: transfer of cutaneous basophil reactions.
    Haynes JD; Rosenstein RW; Askenase PW
    J Immunol; 1978 Mar; 120(3):886-94. PubMed ID: 344798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of endothelial selectins and alpha 4 integrins to eosinophil trafficking in allergic and nonallergic inflammatory reactions in skin.
    Teixeira MM; Hellewell PG
    J Immunol; 1998 Sep; 161(5):2516-23. PubMed ID: 9725251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.
    König W; Czarnetzki BM; Lichtenstein LM
    J Immunol; 1976 Jul; 117(1):235-41. PubMed ID: 932426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts.
    Postlethwaite AE; Kang AH
    J Immunol; 1980 Mar; 124(3):1462-6. PubMed ID: 7358987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of three macrophage chemotactic factors from PPD-induced delayed hypersensitivity reaction sites in guinea pigs, with special reference to a chemotactic lymphokine.
    Honda M; Hayashi H
    Am J Pathol; 1982 Aug; 108(2):171-83. PubMed ID: 6765857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and characterization of lymphocyte mitogenic factor released in vivo during a cell-mediated immune reaction in the guinea pig.
    Postlethwaite AE
    J Immunol; 1980 Nov; 125(5):1955-8. PubMed ID: 6968767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Difference in requirement of macrophage products for concanavalin A-induced production of eosinophil chemotactic factor and macrophage chemotactic factor from guinea pig lymphocytes in vitro.
    Hirashima M; Tashiro K; Sakata K; Yoshimura T; Hayashi H
    J Immunol; 1984 Oct; 133(4):2012-7. PubMed ID: 6470485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of eosinophil chemotactic factor in localized tissue eosinophilia by parasitic infection].
    Ishimitsu T; Torisu M
    Nihon Rinsho; 1993 Mar; 51(3):675-80. PubMed ID: 8492442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous production of eosinophil chemotactic factors by T lymphocytes from patients with subcutaneous angioblastic lymphoid hyperplasia with eosinophilia.
    Hirashima M; Sakata K; Tashiro K; Ohmori J; Iyama K; Tsuda H; Nagai T; Hiraoka T; Kimura T
    Clin Immunol Immunopathol; 1986 May; 39(2):231-41. PubMed ID: 3084142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of eosinophil leukocyte chemotaxis by a factor in normal human serum (SEF).
    Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1979; 60(3):315-24. PubMed ID: 489135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The chemical mediation of delayed hypersensitivity skin reactions. IV. Activation of chemotactic factor precursor by a trypsin-like protease in guinea pig plasma.
    Kawaguchi T; Ueda K; Yamamoto T; Kambara T
    Am J Pathol; 1984 May; 115(2):307-15. PubMed ID: 6372498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotactic macrophage subpopulations defined by macrophage chemotactic factors from delayed hypersensitivity reaction sites.
    Honda M; Yoshimura T; Watanabe T; Hayashi H
    J Immunol; 1983 Dec; 131(6):2989-94. PubMed ID: 6196408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of eosinophil chemotactic factor (ECF) in basophils and mast cells.
    Czarnetzki B; Sonak R; Macher E
    Monogr Allergy; 1979; 14():281-4. PubMed ID: 503080
    [No Abstract]   [Full Text] [Related]  

  • 59. A novel eosinophil chemotactic factor derived from a histiocytic lymphoma of the central nervous system.
    Goetzl EJ; Rothenberg J; Weber EL; Sinn CM; Austen KF
    Clin Exp Immunol; 1980 May; 40(2):249-55. PubMed ID: 7438536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of inflammatory cytokines in a delayed-type hypersensitivity reaction.
    Higashi N; Yoshizuka N; Ohuchi A; Osawa T; Kobayashi Y
    Cell Immunol; 1995 Apr; 161(2):288-94. PubMed ID: 7697740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.